Related references
Note: Only part of the references are listed.
Article
Psychology, Clinical
Don E. Willis et al.
Summary: This survey investigated attitudes towards COVID-19 vaccines among adults vaccinated in Arkansas. The results showed that 60% of the vaccinated individuals reported some level of hesitancy, with 10% being very hesitant. Hesitancy was associated with factors such as age, sex, race/ethnicity, health care coverage, health literacy, and flu vaccination history.
JOURNAL OF BEHAVIORAL MEDICINE
(2023)
Article
Oncology
Mike Nguyen et al.
Summary: This study investigated the COVID-19 vaccine uptake and hesitancy among patients with solid organ and blood cancers. The results showed that a significant proportion of patients remained unvaccinated, despite being eligible for vaccination. Vaccine uptake was associated with factors such as age, gender, language, time since cancer diagnosis, and current anticancer treatment. Concerns about side effects and the desire for medical advice were prominent among unvaccinated patients.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
(2022)
Review
Immunology
Manuela Di Fusco et al.
Summary: A targeted literature review summarized 10 studies conducted between December 2020 and September 2021, revealing lower effectiveness of COVID-19 vaccines among immunocompromised populations compared to the general populations. It emphasizes the need for additional protective measures for immunocompromised individuals to prevent infection and associated illness.
EXPERT REVIEW OF VACCINES
(2022)
Article
Psychology, Clinical
Daniel Freeman et al.
Summary: The study aimed to estimate the willingness to receive a COVID-19 vaccine, identify predictive socio-demographic factors, and determine potential causes in order to provide guidance on information provision. The findings showed that willingness to take the vaccine is closely linked to recognition of its collective importance, and factors such as conspiracy beliefs lower vaccine uptake. Socio-demographic factors such as age, gender, income, and ethnicity also played a role in vaccine hesitancy.
PSYCHOLOGICAL MEDICINE
(2022)
Article
Public, Environmental & Occupational Health
Richard Tsai et al.
Summary: This study investigated COVID-19 vaccine hesitancy and acceptance among individuals with comorbid conditions. Significant vaccine hesitancy was found, and early self-reported side effect experiences among those who had already been vaccinated may help alleviate vaccine fears. Health care-related social media forums may play an important role in disseminating accurate information about COVID-19 vaccines.
JMIR PUBLIC HEALTH AND SURVEILLANCE
(2022)
Article
Oncology
Svenja Heyne et al.
Summary: This study aimed to assess the attitudes towards COVID-19 vaccine among cancer patients and their vaccination status, as well as explore additional factors that may influence these attitudes. The majority of participants expressed positive attitudes towards the vaccine, with a high vaccination rate. Fear of side effects was the most commonly mentioned reason for not getting vaccinated. There was no significant correlation between vaccination status and anxiety symptomatology or health literacy.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Jeffrey V. Lazarus et al.
Summary: Survey data from 19 countries reveals varying attitudes towards acceptance of a COVID-19 vaccine, with trust in government being linked to vaccine confidence.
Review
Immunology
Malik Sallam
Summary: COVID-19 vaccine acceptance rates are generally high worldwide, but low rates are reported in the Middle East, Russia, Africa, and certain European countries. This could pose a significant challenge in global efforts to control the pandemic. More studies are recommended to address COVID-19 vaccine hesitancy in different regions.
Editorial Material
Clinical Neurology
Yun Huang et al.
Summary: The study found that the majority of people with multiple sclerosis (pwMS) are willing to receive the COVID-19 vaccine, with factors like previous influenza vaccination, older age, and perceived knowledge about the vaccine increasing the likelihood of vaccination. However, there was a significant difference in vaccination rates based on prior opinions, highlighting the importance of providing more information on the safety of COVID-19 vaccines for pwMS to make informed decisions.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
(2021)
Article
Oncology
Leticia Monin et al.
Summary: The study aimed to evaluate the safety and immunogenicity of the BNT162b2 vaccine in cancer patients. The results showed poor efficacy of a single vaccine dose in cancer patients, with significantly increased immunogenicity in solid cancer patients after a vaccine boost at day 21. Therefore, it is recommended to prioritize cancer patients for an early second dose on day 21.
Article
Medicine, General & Internal
S. A. Madhi et al.
Summary: The ChAdOx1 nCoV-19 vaccine did not provide significant protection against mild-to-moderate Covid-19 caused by the B.1.351 variant, with an efficacy of 10.4%. The incidence of serious adverse events was balanced between the vaccine and placebo groups.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Medicine, General & Internal
M. G. Thompson et al.
Summary: A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines (>= 14 days after the second dose) were highly effective against SARS-CoV-2 infection leading to hospitalization (89%), ICU admission (90%), or an urgent care visit (91%).
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Biotechnology & Applied Microbiology
Tina Ko et al.
Summary: The study found that patients with rheumatic diseases have vaccine hesitancy towards SARS-COV-2 vaccine and are concerned about the safety, efficacy, side effects, and disease exacerbation of the vaccine. However, clinician recommendation, vaccine choice, and communication addressing patient concerns can facilitate vaccine acceptance.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Immunology
Wing-Lok Chan et al.
Summary: This study in Hong Kong found that only 17.9% of cancer patients were willing to accept COVID-19 vaccination, with many expressing concerns about negative effects on cancer and its side effects. Factors associated with acceptance included belief in vaccine efficacy, less worry about long-term side effects, lower cancer health literacy, and normal levels of depression. Improving vaccine acceptance in this group will require targeted public education campaigns to build trust in efficacy and ease worries.
Article
Oncology
Vincenzo Di Noia et al.
Summary: This study reported on the compliance with COVID-19 vaccination among patients affected by solid tumors, revealing concerns about vaccine-related adverse events, negative interactions with concomitant antitumor therapy, and fear of allergic reactions as common reasons for refusal. Additionally, the refusal rate more than doubled after the suspension of AstraZeneca-AZD1222, indicating the impact of regulatory decisions and media news on vaccination campaigns.
EUROPEAN JOURNAL OF CANCER
(2021)
Article
Health Care Sciences & Services
Amar H. Kelkar et al.
Summary: Clinical oncologists can influence cancer patients' attitudes towards COVID-19 vaccination, and positive communication about vaccines can increase enthusiasm for vaccination.
Editorial Material
Medicine, General & Internal
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Article
Psychology, Multidisciplinary
Steven Taylor et al.
FRONTIERS IN PSYCHOLOGY
(2020)
Article
Immunology
Noni E. MacDonald
Review
Biotechnology & Applied Microbiology
Eve Dube et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2013)
